Brian Johnson

In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004)

Daryl J. Hoban, Samuel K. Bouchillon, Brian Johnson et al. · Diagnostic Microbiology and Infectious Disease · 2005 · 205 citations

Medicine, Infectious Diseases, Pharmacology +7

Determining incidence of extended spectrum β-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001–2002

S. Bouchillon, Brian Johnson, D. Hoban et al. · International Journal of Antimicrobial Agents · 2004 · 141 citations

Life Sciences, Infectious Diseases, Microbiology +17

In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004)

Samuel K. Bouchillon, Daryl J. Hoban, Brian Johnson et al. · Diagnostic Microbiology and Infectious Disease · 2005 · 88 citations

Medicine, Infectious Diseases, Pharmacology +7

In vitro evaluation of tigecycline and comparative agents in 3049 clinical isolates: 2001 to 2002

Samuel K. Bouchillon, Daryl J. Hoban, Brian Johnson et al. · Diagnostic Microbiology and Infectious Disease · 2005 · 56 citations

Medicine, Infectious Diseases, Pharmacology +5

Molecular Characterization of Methicillin-Susceptible Staphylococcus aureus Clinical Isolates in the United States, 2004 to 2010

Benjamin A. Miko, Cory Hafer, Caroline J. Lee et al. · Journal of Clinical Microbiology · 2013 · 51 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17